← Back to Search

Cryobiopsy for Interstitial Lung Disease

N/A
Waitlist Available
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Volunteer subjects with interstitial lung disease in whom a surgical lung biopsy is planned for diagnostic investigation.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after biopsy (up to 24months)
Awards & highlights

Study Summary

This trial evaluates the safety and effectiveness of two procedures for diagnosing interstitial lung disease.

Eligible Conditions
  • Interstitial Lung Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after biopsy (up to 24months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and after biopsy (up to 24months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall diagnostic yield of cryobiopsy specimens in interstitial lung disease
Secondary outcome measures
Complication rate of transbronchial cryobiopsy procedure
Inter-observer agreement for cryobiopsy specimens
Number of diagnostic specimens of cryoTBB in comparison with surgical lung biopsy specimen
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CryobiopsyExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
418 Previous Clinical Trials
172,232 Total Patients Enrolled
Antoine Delage, MDCMStudy ChairInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby May 2025